Alli weight-loss drug

Alli weight-loss drug

C022/6891 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 50.0MB

Downloadable file size: 794.7KB

Price image Pricing

Please login to use the price calculator


Restrictions: Editorial Use Only Not to be shared on social media or embedded in a web page without permission.

Caption: Alli weight-loss drug. This is the tradename for the over-the-counter form of the anti-obesity drug orlistat (tetrahydrolipstatin). In prescription form, it is known as Xenical. It works by preventing the absorption of fat from food. Side-effects include loose, oily faeces. Non-prescription (over-the-counter) use was first approved in 2007 and 2009 in the USA and Europe, though in some areas its use is controversial.

Release details: Model release not required. Property release not required.

Keywords: 2014, 21st century, alli, anti obesity, anti-obesity, bottle, brand, brand name, britain, british, capsule, capsules, controlled diet, controversial, cut out, cut outs, cut-out, cut-outs, cutout, cutouts, dietary, england, english, europe, european, fat absorption, glaxosmithkline, medical, medicine, no-one, nobody, non-prescription, orlistat, otc, over the counter, over-the-counter, packaging, packet, pharmaceutics, pharmacological, pharmacology, pill, pills, preventative, prevention, side effect, steatorrhea, still life, still-life, studio shot, tetrahydrolipstatin, tradename, treatment, uk, united kingdom, weight loss aid, weight-loss drug, white background, xenical

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.